Cumberland Pharmaceuticals Inc.

CPIX Healthcare Drug Manufacturers Specialty & Generic

In the quarter to June 2026, revenue fell 56.3%, EPS fell 440.0%, free cash flow fell 82.8% and total debt was flat, each against the same quarter a year earlier.

7.18 0.36 −4.77%
Market cap
$113.0M
P/E
0.0×
Fwd P/E
−12.2×
Dividend yield
0.00%
F-score
6/9
Altman Z
0.65
Beneish M
−2.58
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
29.94 37.06 32.79 33.64
Total non-current assets
35.96 39.76 38.21 29.24
Total Assets
65.90 76.82 71.00 62.88
Total current liabilities
24.31 36.74 34.49 35.19
Total non-current liabilities
15.79 15.53 15.20 10.58
Total liabilities
40.10 52.28 49.69 45.77
Common Equity (Total)
25.80 24.54 21.30 17.11
Shareholders Equity (Total)
25.80 24.54 21.30 17.11
Total Debt
5.24 5.24 5.24 —

Show all line items

In millions of $ except per-share values · columns are period end dates